JDD Buzz Series | Diversity in Melasma Clinical Trials
Underrepresentation of patients with skin of color in clinical trials is an issue in medical research, including in research about dermatological conditions. A study in the January Journal of Drugs in Dermatology looked at the diversity of patients enrolled in melasma clinical trials to determine if there are any disparities in representation.
I interviewed author Jared Jagdeo, MD, MS, associat …
Underrepresentation of patients with skin of color in clinical trials is an issue in medical research, including in research about dermatological conditions. A study in the January Journal of Drugs in Dermatology looked at the diversity of patients enrolled in melasma clinical trials to determine if there are any disparities in representation.
I interviewed author Jared Jagdeo, MD, MS, associat … Continue reading "JDD Buzz Series | Diversity in Melasma Clinical Trials"
As dermatologists, we recognize that melasma is a persistent and often challenging condition that can deeply affect our patients' self-esteem, particularly in those with skin of color, who may face additional diagnostic and therapeutic complexities. Effectively managing this condition requires a nuanced approach, and we are fortunate to have experts like Dr. Seemal Desai, president of the AAD, fou … 
Treating scarring alopecias in patients with skin of color requires a nuanced understanding of their unique clinical features and challenges. Dr. Susan Taylor, Professor of Dermatology at the University of Pennsylvania Perelman School of Medicine (@drsusantaylor), President-Elect of the American Academy of Dermatology (AAD), and founder of the Skin of Color Society, has devoted her career to impro … 
As dermatologists, we recognize that chronic itch is a complex and often debilitating condition that significantly impacts our patients' quality of life, affecting their physical health, mental well-being, and daily activities. Chronic itch can be especially challenging to diagnose and treat, particularly in patients with skin of color, who may experience unique clinical manifestations and complic … 
The many alternatives to hydroquinone make this an exciting time for using cosmeceuticals to treat pigmentary disorders, according to Dr. Heather Woolery-Lloyd, director of the Skin of Color Division at the University of Miami Miller School of Medicine’s Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery. In an interview with Next Steps in Derm, in partnership with Pigmentary Diso … 